Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Mena-Vázquez N, Godoy-Navarrete FJ, Lisbona-Montañez JM, Redondo-Rodriguez R, Manrique-Arija S, Rioja J, Mucientes A, Ruiz-Limón P, Garcia-Studer A, Ortiz-Márquez F, Oliver-Martos B, Cano-García L, Fernández-Nebro A. Mena-Vázquez N, et al. Among authors: oliver martos b. Int J Mol Sci. 2023 Apr 5;24(7):6800. doi: 10.3390/ijms24076800. Int J Mol Sci. 2023. PMID: 37047772 Free PMC article.
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.
Alloza I, Otaegui D, de Lapuente AL, Antigüedad A, Varadé J, Núñez C, Arroyo R, Urcelay E, Fernandez O, Leyva L, Fedetz M, Izquierdo G, Lucas M, Oliver-Martos B, Alcina A, Saiz A, Blanco Y, Comabella M, Montalban X, Olascoaga J, Matesanz F, Vandenbroeck K. Alloza I, et al. Genes Immun. 2012 Apr;13(3):253-7. doi: 10.1038/gene.2011.81. Epub 2011 Dec 1. Genes Immun. 2012. PMID: 22130326
Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-ß Mediation.
Hurtado-Guerrero I, Hernáez B, Pinto-Medel MJ, Calonge E, Rodriguez-Bada JL, Urbaneja P, Alonso A, Mena-Vázquez N, Aliaga P, Issazadeh-Navikas S, Pavia J, Leyva L, Alcamí J, Alcamí A, Fernández Ó, Oliver-Martos B. Hurtado-Guerrero I, et al. J Clin Med. 2020 Mar 31;9(4):959. doi: 10.3390/jcm9040959. J Clin Med. 2020. PMID: 32244308 Free PMC article.
Cumulative inflammatory burden and obesity as determinants of insulin resistance in patients with established rheumatoid arthritis: cross-sectional study.
Manrique-Arija S, Mena-Vazquez N, Ureña I, Rioja J, Valdivielso P, Ginel-Mendoza L, Abad-Sánchez S, Jiménez-Núñez FG, Oliver-Martos B, Fernandez-Nebro A. Manrique-Arija S, et al. Among authors: oliver martos b. BMJ Open. 2021 Feb 9;11(2):e044749. doi: 10.1136/bmjopen-2020-044749. BMJ Open. 2021. PMID: 33563625 Free PMC article.
Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Ciano-Petersen NL, Cabezudo-García P, Muñiz-Castrillo S, Honnorat J, Serrano-Castro PJ, Oliver-Martos B. Ciano-Petersen NL, et al. Among authors: oliver martos b. Int J Mol Sci. 2021 Dec 4;22(23):13127. doi: 10.3390/ijms222313127. Int J Mol Sci. 2021. PMID: 34884930 Free PMC article. Review.
Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder.
Requena-Ocaña N, Araos P, Serrano-Castro PJ, Flores-López M, García-Marchena N, Oliver-Martos B, Ruiz JJ, Gavito A, Pavón FJ, Serrano A, Mayoral F, Suarez J, Fonseca FR. Requena-Ocaña N, et al. Among authors: oliver martos b. Int J Mol Sci. 2023 Jan 7;24(2):1183. doi: 10.3390/ijms24021183. Int J Mol Sci. 2023. PMID: 36674698 Free PMC article.
Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations.
Ciano-Petersen NL, Aliaga-Gaspar P, Hurtado-Guerrero I, Reyes V, Rodriguez-Bada JL, Rodriguez-Traver E, Brichette-Mieg I, Leyva Fernández L, Serrano-Castro P, Alonso A, Oliver-Martos B. Ciano-Petersen NL, et al. Among authors: oliver martos b. Front Immunol. 2023 Aug 22;14:1242508. doi: 10.3389/fimmu.2023.1242508. eCollection 2023. Front Immunol. 2023. PMID: 37675113 Free PMC article.
Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab.
Dominguez-Mozo MI, Perez-Perez S, Villar LM, Oliver-Martos B, Villarrubia N, Matesanz F, Costa-Frossard L, Pinto-Medel MJ, García-Sánchez MI, Ortega-Madueño I, Lopez-Lozano L, Garcia-Martinez A, Izquierdo G, Fernández Ó, Álvarez-Cermeño JC, Arroyo R, Alvarez-Lafuente R. Dominguez-Mozo MI, et al. Among authors: oliver martos b. Sci Rep. 2020 Aug 28;10(1):14244. doi: 10.1038/s41598-020-71283-5. Sci Rep. 2020. PMID: 32859922 Free PMC article.
33 results